Drug name - Doryx

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6958161 MAYNE PHARMA Modified release coated drug preparation Dec, 2022

(2 months from now)

US8715724 MAYNE PHARMA Tabletting process Feb, 2028

(5 years from now)

US9295652 MAYNE PHARMA Controlled release doxycycline Oct, 2034

(12 years from now)

US9511031 MAYNE PHARMA Controlled release doxycycline Oct, 2034

(12 years from now)

US9446057 MAYNE PHARMA Controlled release doxycycline Dec, 2034

(12 years from now)

Drugs and Companies using DOXYCYCLINE HYCLATE ingredient

Treatment: To treat or prevent infections caused by susceptible bacteria using delayed-release tablets consisting of doxycycline hyclate coated pellets in a tablet

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 50MG BASE TABLET, DELAYED RELEASE;ORAL Prescription
EQ 75MG BASE TABLET, DELAYED RELEASE;ORAL Prescription
EQ 80MG BASE TABLET, DELAYED RELEASE;ORAL Prescription
EQ 100MG BASE TABLET, DELAYED RELEASE;ORAL Prescription
EQ 150MG BASE TABLET, DELAYED RELEASE;ORAL Prescription
EQ 200MG BASE TABLET, DELAYED RELEASE;ORAL Prescription
EQ 60MG BASE TABLET, DELAYED RELEASE;ORAL Discontinued
EQ 120MG BASE TABLET, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.